Physician profile
Eman Zedan
NPI 1861929101
$879.39
in general payments reported to CMS, 2019-2025
10 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $81.67 · 2022: $103 · 2023: $138 · 2024: $253 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $694.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $370.36 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $156.86 | 2021-2025 | Wegovy |
| Lilly USA, LLC | $112.88 | 2021-2025 | Mounjaro, Jardiance |
| Merck Sharp & Dohme LLC | $56.52 | 2021-2022 | |
| Phadia US INC. | $54.42 | 2023-2024 | Immunocap |
| Abbvie INC. | $42.00 | 2021-2023 | |
| Acadia Pharmaceuticals INC | $40.19 | 2025 | Nuplazid |
| Amgen INC. | $16.83 | 2024 | Otezla, Repatha |
| Azurity Pharmaceuticals, INC. | $15.00 | 2023 | Adthyza |
| Pfizer INC. | $14.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eman Zedan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.